Outcomes and Economic Benefits of Penn State Extension’s Dining With Diabetes Program

Details

• Journal Article:
  Preventing Chronic Disease (PCD)
• Personal Author:
  Griffie, Debra ; James, Lynn ; Goetz, Stephan ; Balotti, Brandon ; Shr, Yau-Huo ; Corbin, Marilyn ; Kelsey, Timothy W.
• Description:
  Introduction
  
  Many diabetes education programs address the problem of diabetes, but little attention is given to the economic impact of such programs. Our objective was to assess the effectiveness of a community-based education program in improving diabetes-related lifestyle behaviors and biomarkers and ascertain the economic benefits of the program for adults aged 18 years or older with type 2 diabetes, prediabetes, or no diagnosis of diabetes in Pennsylvania.
  
  Methods
  
  From October 2012 through June 2015, Pennsylvania State University Extension’s Dining with Diabetes program collected data on 2,738 adults with type 2 diabetes or prediabetes and adult family members without diabetes. The program consisted of 4 weekly 2-hour classes and a follow-up class conducted 3 months after the fourth 2-hour class. In the initial class and the follow-up class, participants completed a lifestyle questionnaire and their hemoglobin A1c and blood pressure were measured. Economic benefit was calculated as the medical expenditure cost savings resulting from program participation.
  
  Results
  
  At 3-month follow-up, a significant number of participants had improved their lifestyle behaviors (diet and physical activity), had reductions in hemoglobin A1c and blood pressure, and improved their diabetes status. The Dining with Diabetes program had a 5-year benefit–cost ratio of 2.49 to 3.35.
  
  Conclusion
  
  Participants who completed the Dining with Diabetes program had significant improvements in diabetes-related biomarkers and lifestyle behaviors. If the Dining with Diabetes program were extended to half of the 1.3 million people living with diabetes in Pennsylvania and if they had similar improvements, the 1-year benefit to the state would be approximately $195 million, assuming a conservative 15% decrease in direct medical costs.
  
  
• Subjects:
  Adolescent Adult Biomarkers Blood Pressure Cost-Benefit Analysis Diabetes Mellitus, Type 2 Female Humans Life Style Male Middle Aged Patient Participation Prediabetic State Treatment Outcome Universities Young Adult

  More +
• Source:
  Prev Chronic Dis. 15.
• DOI:
  http://dx.doi.org/10.5888/pcd15.170407
• ISSN:
  1545-1151
• Pubmed ID:
  29729134
• Pubmed Central ID:
  PMC5951670
• Document Type:
  Journal Article
• Place as Subject:
  Pennsylvania
• Location:
  North America
• Volume:
  15
• Collection(s):
  Preventing Chronic Disease
• Main Document Checksum:
  urn:sha-512:9e807b05fbf97eb8129012a54046272499bdde33d36df7b4a976884b85ff66555d5c1959e2f98569fbac9aac11d602a933ee4eb6a33cc6ad3117550eebd96220
• Download URL:
  https://stacks.cdc.gov/view/cdc/55292/cdc_55292_DS1.pdf
• File Type:
  [PDF - 410.73 KB ]